Recursion Pharmaceuticals Statistics
NASDAQ: RXRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
4.27-0.36 (-7.78%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Recursion Pharmaceuticals by the numbers
Recursion Pharmaceuticals has a market capitalization of $2.29 billion based on 535.34M shares outstanding. With trailing EPS of $-1.00, Recursion Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.5% above its 50-day average and 19.4% above its 200-day average.
Average daily trading volume is 20.28M shares, or about $86.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RXRX valuation vs. peer median
| Metric | RXRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.29B | $2.09B | +10% |
| Avg. volume | 20.28M | 1.91M | +963% |
Peer median across 8 companies: ADMA, BCRX, ALVO, VCEL, BEAM, VIR, NVAX, MESO.
Valuation
- Market cap
- $2.29B
- EPS (TTM)
- $-1.00
- Shares outstanding
- 535.34M
Price and trading
- Previous close
- 4.63
- Open
- 4.51
- Day range
- 4.23 – 4.60
- 52-week range
- 2.77 – 7.18
- 52-week change
- -18.36%
- Beta
- —
- Volume
- 40.48M
- Average volume
- 20.28M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 2.29B
- Forward Pe
- -4.73
- Eps
- -1.00
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.18
- Week52 Low
- 2.77
- Avg Volume
- 20.28M
- Shares Outstanding
- 535.34M
- Ma50
- 3.49
- Ma200
- 3.58
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -40.53%
- Pct From52w Low
- 54.15%